...
首页> 外文期刊>Bone marrow transplantation >Parvovirus B19 as an etiological agent of acute pleuro-pericarditis.
【24h】

Parvovirus B19 as an etiological agent of acute pleuro-pericarditis.

机译:细小病毒B19是急性胸膜外心包炎的病原体。

获取原文
获取原文并翻译 | 示例
           

摘要

Infectious complications, whether associated or not with GVHD and its treatment, are a constant concern after allo-SCT. Viral infections are of particular concern because of difficulty in diagnosis, variable clinical presentation and propensity to disseminate owing to the immunological status of grafted patients. We report a case of severe pleuro-pericarditis associated with Parvovirus B19 infection in an allografted patient. A 40-year-old Caucasian man was diagnosed in April 2001 with chronic myeloid leukemia, in chronic phase. The Sokal score was low and the patient was treated with alpha-IFN and hydroxyurea, without hematological response after 6 months. Imatinib therapy was started and a hematological complete response was achieved after 1 month. Unfortunately, 4 months later, acute myeloid transformation was evident (marrow blasts 51%) and he received a classical 3 + 7 induction chemotherapy for AML, which resulted in a second chronic phase.
机译:异源性SCT治疗后,无论是否与GVHD及其治疗相关的感染性并发症一直是关注的焦点。由于移植患者的免疫学状况,其诊断困难,临床表现多样且易于传播,因此特别需要关注病毒感染。我们报道一例同种异体移植患者中与细小病毒B19感染相关的严重胸膜心包炎。一名40岁的白人男子于2001年4月被诊断为慢性粒细胞性白血病,处于慢性期。 Sokal评分低,患者接受α-IFN和羟基脲治疗,六个月后无血液学反应。开始伊马替尼治疗,并在1个月后达到血液学完全缓解。不幸的是,在4个月后,明显的急性髓样转化(骨髓胚发生5​​1%),他接受了经典的3 + 7 AML诱导化疗,导致了第二个慢性期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号